Chemically Defined Medium for Pluripotent Stem Cell Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for maintaining pluripotency in human pluripotent stem cells (hPSCs) are inefficient and often rely on undefined or xenogenic components, leading to batch-to-batch variations and safety concerns.

Innovation Solution

A chemically defined medium comprising water, a carbon source, vitamins, salts, fatty acids, buffer components, selenium, a FIASMA (such as trimipramine), and a TGF-β superfamily member (such as activin a) that inhibits stem cell differentiation, allowing for the expansion and maintenance of undifferentiated hPSCs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If undefined or xenogenic components are used in the culture medium, then the medium can support hPSC proliferation, but batch-to-batch variations and safety concerns arise

Engineering Contradiction:
ImprovehPSC proliferationVSAvoidbatch-to-batch consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent transitions from undefined to chemically defined medium composition, specifying exact concentrations of nutrients, growth factors (FGF-2, TGF-β1), and additives. This parameter standardization eliminates batch-to-batch variations while maintaining hPSC proliferation capacity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent removes xenogenic components (animal-derived substances) from the culture medium formulation, extracting only the essential nutrients and growth factors needed for hPSC maintenance. This extraction eliminates safety concerns associated with xenogenic substances while preserving cell proliferation.

Inventive Principle:
Principle #2Taking out (Extraction)

2Reliability

If FGF-2 is added to the medium to maintain pluripotency, then hPSC self-renewal is supported, but the medium becomes more complex and expensive

Engineering Contradiction:
Improvepluripotency maintenanceVSAvoidmedium composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent optimizes the concentration parameters of FGF-2 and TGF-β1 to physiological ranges, reducing the amounts needed while maintaining pluripotency. This parameter optimization simplifies the medium composition and reduces costs while preserving the self-renewal function.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If human or animal-derived substances are used, then the medium can support cell growth, but safety and ethical concerns arise

Engineering Contradiction:
Improvecell growth supportVSAvoidsafety and ethical concerns
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent completely removes human or animal-derived substances from the medium formulation, replacing them with chemically defined, xeno-free components. This extraction eliminates safety and ethical concerns while maintaining cell growth support through synthesized alternatives.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs chemically synthesized, disposable medium components that replace expensive and ethically problematic animal-derived substances. These synthetic components are safe, ethically unblemished, and can be consistently produced without biological variability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS12234484B2Culture medium for pluripotent stem cells
Publication Date: 2025.02.25 PROMOCELL GMBH
  • US12234484B2 patent drawing
  • US12234484B2 patent drawing
  • US12234484B2 patent drawing

AI summary

The present invention relates to a chemically defined medium for eukaryotic cell culture, comprising water, at least one carbon source, one or more vitamins, one or more salts, one or more fatty acids, one or more buffer components, selenium, at least one substance of the group of Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and at least one polypeptide of the TGF-β superfamily with the ability to inhibit stem cell differentiation, its use in the culture of human pluripotent stem cells, a cell culture system comprising human pluripotent stem cells and the chemically defined medium, as well as a kit for proliferation and/or maintenance of human pluripotent stem cells.